The ROR2 expression is also increased in human non-small cell lung cancer (NSCLC) and correlates with an advanced TNM stage, indicating that ROR2 might be an independent prognostic factor in NSCLC [5]. The gene discussed is ROR2; the disease is non-small cell lung carcinoma.